株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヒトES細胞(hESC):世界市場の概要

Human Embryonic Stem Cells (hESC) - A Global Market Overview

発行 Industry Experts 商品コード 125371
出版日 ページ情報 英文 216 pages
即納可能
価格
こちらの商品の販売は終了いたしました。
Back to Top
ヒトES細胞(hESC):世界市場の概要 Human Embryonic Stem Cells (hESC) - A Global Market Overview
出版日: 2010年07月20日 ページ情報: 英文 216 pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当レポートでは、世界のヒトES細胞(hESC)市場について、製品および技術概要、治療分野と特許動向とともに、地域別市場動向と参入企業の概要をまとめ、概略以下の構成でお届けします。

第1章 世界市場の展望

  • イントロダクション
  • 製品セグメント
    • ヒトES細胞の技術
      • 幹細胞移植
      • 細胞ベースゲノミクス
      • 異種移植
      • その他の技術
    • ヒトES細胞の治療分野
      • 中枢神経系
      • 組織エンジニアリング
      • 腫瘍
      • 心臓
      • その他
    • ヒトES細胞研究の賛否両論
  • 世界のヒトES細胞と特許概要
    • 米国
    • 欧州
    • アジア太平洋諸国
  • 既存の幹細胞政策概要
    • 地域別ヒトES細胞研究方針
    • 幹細胞研究の現状
  • 市場動向
  • 主な参入企業
    • 米国
    • カナダ
    • デンマーク
    • フランス
    • ドイツ
    • ノルウェー
    • スウェーデン
    • スイス
    • 英国
    • オーストラリア
    • 中国
    • インド
    • 日本
    • マレーシア
    • シンガポール
    • 韓国
    • 台湾
    • イスラエル
  • 主なビジネス動向
  • 世界市場概要
    • ヒトES細胞技術別市場概要
    • ヒトES細胞治療分野別市場概要
    • 地域別ヒトES細胞技術市場概要
    • 地域別ヒトES細胞治療分野市場概要

第2章 地域別市場の展望

  • 地域別市場の概要
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他

第3章 産業ガイド

  • 北米
    • カナダ
    • 米国
  • 欧州
    • デンマーク
    • フランス
    • ドイツ
    • ノルウェー
    • スペイン
    • スウェーデン
    • スイス
    • オランダ
    • 英国
  • アジア太平洋地域
    • オーストラリア
    • 中国
    • インド
    • 日本
    • 韓国
    • マレーシア
    • シンガポール
    • 台湾
    • タイ
  • その他地域
    • イスラエル
    • 南アフリカ

第4章 付録

  • 調査手法
  • アンケート
  • フィードバック

図表

目次
Product Code: BT007

Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.

Embryonic Stem Cell Technologies analyzed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas.The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015, .

The report reviews, analyses and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 12 independent countries across North America - United States, Canada and Mexico; Europe - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific - India, China, Japan, Australia and Rest of Asia-Pacific.

This 216 page global market report includes 106 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments. The study also profiles 41 key global players and 55 major players across North America - 28; Europe - 15; Asia-Pacific - 10 and Rest of World - 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of hESCs. The global list of companies covers addresses, contact numbers and the website addresses of 184 companies.

Table of Contents

1. GLOBAL MARKET PERSPECTIVE

  • 1.1 Introduction
  • 1.2 Product Segmentation
    • 1.2.1 Technologies of hESCs
      • 1.2.1.1 Stem Cell Transplants
        • Infarcted Myocardium to be repaired by Human Embryonic Stem Cell Transplantation
        • Oligodendrocyte Progenitor Cell Transplants Derived from Human Embryonic Stem Cells Enhance Recovery after Cervical Spinal Cord Injury
        • Human Embryonic Stem Cell-Derived Cardiomyocytes Transplantation Improves Myocardial Performance in Infarcted Rat Hearts
      • 1.2.1.2 Cell Based Genomics
        • Genomic Alterations in Cultured Human Embryonic Stem Cells
        • Gene Expression in Human Embryonic Stem Cell Lines: Unique Molecular Signature
        • GeneChip Analysis of Human Embryonic Stem Cell Differentiation into Hemangioblasts: An In Silico Dissection of Mixed Phenotypes
      • 1.2.1.3 Xenotransplantation
      • 1.2.1.4 Other Stem Cell Technologies
    • 1.2.2 Therapeutic Areas of hESCs
      • 1.2.2.1 Central Nervous System
      • 1.2.2.2 Tissue Engineering
        • Endochondral Bone Tissue Engineering Using Embryonic Stem Cells
        • Bone Tissue Engineering in an Orthotopic Defect
        • Discussion
      • 1.2.2.3 Oncology
        • Embryonic Stem Cells Reveal Secret Growth Formula of Oncogene
      • 1.2.2.4 Cardiology
      • 1.2.2.5 Other Therapeutic Areas
        • Blood Disorders
        • Diabetes
        • Muscular Dystrophy
        • Stem Cell Therapy for Spinal Cord Injury
    • 1.2.3 Pros and Cons of Embryonic Stem Cell Research
  • 1.3 Snapshot on Global hESC Laws and Patents
    • 1.3.1 The United States
      • Patent on Human Embryonic Stem Cells Rejected After Consumer Groups' Appeal
    • 1.3.2 Europe
      • Stem Cell Patent Rejected by Europe
    • 1.3.3 Asia-Pacific
      • China
      • Laws and Regulations
      • Cultural Views
      • Australia
      • India
      • Indonesia
      • Japan
      • Taiwan
      • Patent Policy
      • Thailand
      • Singapore
      • South Korea
  • 1.4 A Glance at Existing Stem Cell Research Policies Worldwide
    • 1.4.1 hESC Research Policy by Region
      • North America
      • Europe
      • Asia-Pacific
      • Rest of World
    • 1.4.2 Status of Stem Cell Research
  • 1.5 Market Trends
    • Human Embryonic Stem Cells Hold Promises for Medical Advances
    • hESC In Toxicology Applications
    • Stem Cells Hold Promise to Predict Disease and Drug Toxicity
    • Scientists Create More Pluripotent Human Embryonic Stem Cells
    • Latest Trends in Treating HIV and AIDS with Stem Cell Therapies
    • Embryonic Stem Cells Promise New Cures
    • Does Bill Expanding Obama' s Embryonic Stem Cell Research Order Promote Cloning?
    • Israeli Stem Cell Researchers Achieve Breakthrough in Cell Growth Method
    • Reactive Oxygen Species Enhance Differentiation of hESCs into Mesendodermal Lineage
    • Federal Policy Allows Funding for New hESC Lines but not all Investigators are Happy with the Changes
    • Human Skin Grown from Stem Cells to Help Burns Victims
    • UCI Embryonic Stem Cell Therapy Restores Walking Ability in Rats with Neck Injuries
    • Human Embryonic Stem Cell Differentiation on Periodontal Ligament Fibroblasts
    • Technique Enables Efficient Gene Splicing in Human Embryonic Stem Cells
    • Human Sperm Created from Embryonic Stem Cells
    • hESC Technologies and Drug Discovery
    • Stem Cell Therapy for Blindness
    • Expansion and Differentiation of hESC to Endoderm Progeny in a Microcarrier Stirred-Suspension Culture
    • Geron Commences Human Embryonic Stem Cell Therapy for Spinal Cord Injuries
    • Nanotechnology for Regenerative Medicine: Nanomaterials for Stem Cell Imaging
    • Therapeutic Potential of hESC in Parkinson' s disease
  • 1.6 Key Global Players
    • Advanced Cell Technology, Inc
    • Amgen
    • Angel Biotechnology
    • Australian Stem Cell Centre
    • Axiogenesis AG
    • BD Biosciences
    • BioTime
    • Boehringer-Ingelheim GmbH
    • Cellartis AB
    • CellResearch Corporation Pte Ltd
    • Cellular Dynamics International
    • ESTOOLS
    • Gamida Cell Ltd.
    • GE Healthcare
    • Geron Corporation
    • GlobalStem Inc
    • International Stem Cell Corporation
    • Millipore Corporation
    • National Human Neural Stem Cell Resource
    • Novartis AG
    • Novo Nordisk A/B
    • PerkinElmer Inc.
    • Pfizer
    • R&D Systems, Inc.
    • Regenics A/S
    • Reliance Life Sciences
    • RNL BIO
    • SA Biosciences Corporation
    • Sanofi-Aventis
    • Scottish Stem Cell Network
    • SinoCells BioTechnologies Co., Ltd.
    • Stem Cell Network
    • Stem Cell Sciences KK
    • StemCells Inc.
    • Stemina Biomarker Discovery, Inc.
    • StemTech International Sdn Bhd
    • Taiwan Society for Stem Cell Research
    • Thermo Fisher Scientific Inc
    • UK National Stem Cell Network
    • UK Stem Cell Bank (UKNSCB)
    • ViaCell, Inc.
  • 1.7 Key Business Trends
    • BioTime, Inc Acquires ES Cell International Pte Ltd
    • PerkinElmer to Acquire Signature Genomic Laboratories, LLC
    • Proxeon Acquired by Thermo Fisher Scientific
    • Stemgent, Pfizer in a Collaboration Research and Licensing Agreement
    • Thermo Fisher Scientific Takes Over Ahura Scientific
    • Human Embryonic Stem Cells with Enhanced Pluripotency Created by Scientists
    • Stemcell Technologies Inc Releases Two NEW Human Treg Cell Isolation Kits
    • Pfizer Acquires Wyeth
    • Thermo Fisher Scientific Acquires B.R.A.H.M.S.
    • PerkinElmer Takes Over Prenatal and Newborn Screening Laboratory in India
    • StemCells, Inc Plans to Enhance Cell-Based Technologies for Pharmaceutical Industry and Research Applications
    • Thermo Fisher Scientific to Acquire Biolab
    • Embryome Sciences, Inc Enters into an Agreement with Reproductive Genetics Institute
    • StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc
    • Geron Gets the Green Signal from FDA to Begin World' s First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
    • Advanced Cell Technology, Inc and CHA Biotech Co, Ltd in a Joint Venture
    • BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit Launched by BD Biosciences
    • BioTime to Work with Longevity Center on Regenerative Medicine Research
    • Embryome Sciences, Inc. Acquires Exclusive License for ACTCellerate Technology
    • Thermo Fisher Scientific Acquires Affinity BioReagents
    • Thermo Fisher Scientific Acquires Open Biosystems
    • MedCell Joins Forces with NovaThera
    • Pfizer Acquires Encysive Pharmaceuticals Inc
    • BD Acquires Cytopeia
    • Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement
    • BI Biotech India Pvt. Ltd, GlobalStem Inc Enter into Partnership
  • 1.8 Global Market Overview
    • 1.8.1 Market Overview by hESC Technology
    • 1.8.2 Market Overview by hESC Therapeutic Area
    • 1.8.3 hESC Technology Market Overview by Global Region
      • 1.8.3.1 Stem Cell Transplants
      • 1.8.3.2 Cell Based Genomics
      • 1.8.3.3 Xenotransplants
      • 1.8.3.4 Other Stem Cell Technologies
    • 1.8.4 hESC Therapeutic Area Market Overview by Global Region
      • 1.8.4.1 Central Nervous System (CNS)
      • 1.8.4.2 Tissue Engineering
      • 1.8.4.3 Oncology
      • 1.8.4.4 Cardiology
      • 1.8.4.5 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE

  • 2.1 Regional Market Overview
    • 2.1.1 North America
      • 2.1.1.1 Market Overview by North American Region
      • 2.1.1.2 Market Overview by hESC Technology
      • 2.1.1.3 Market Overview by hESC Therapeutic Area
      • 2.1.1.4 hESC Technology Market Overview by North American Region
        • Stem Cell Transplants
        • Cell Based Genomics
        • Xenotransplants
        • Other Stem Cell Technologies
      • 2.1.1.5 Major Market Players
        • Amgen
        • Advanced Cell Technology, Inc
        • Americans for Cures Foundation
        • Angioblast Systems, Inc
        • BD Biosciences
        • BioTime
        • California Stem Cell
        • Cellular Dynamics International
        • Geron Corporation
        • GlobalStem Inc
        • International Society for Stem Cell Research
        • International Stem Cell Corporation
        • Millipore Corporation
        • National Human Neural Stem Cell Resource
        • PerkinElmer Inc.
        • Pfizer
        • R&D Systems, Inc.
        • SA Biosciences Corporation
        • Stem Cell Network (Canada)
        • Stem Cell Technologies (Canada)
        • Stem Cell Therapy International Corporation
        • StemCells Inc.
        • Stemina Biomarker Discovery, Inc.
        • The New York Stem Cell Foundation
        • Thermo Fisher Scientific Inc
        • ViaCell, Inc.
        • ViaCyte
        • WiCell International Stem Cell (WISC) Bank
      • 2.1.1.6 North American Market Overview by Country
        • The United States
        • Canada
        • Mexico
    • 2.1.2 Europe
      • 2.1.2.1 Market Overview by European Region
      • 2.1.2.2 Market Overview by hESC Technology
      • 2.1.2.3 Market Overview by hESC Therapeutic Area
      • 2.1.2.4 hESC Technology Market Overview by European Region
        • Stem Cell Transplants
        • Cell Based Genomics
        • Xenotransplants
        • Other Stem Cell Technologies
      • 2.1.2.5 Major Market Players
        • Angel Biotechnology (United Kingdom)
        • Axiogenesis AG (Germany)
        • Boehringer-Ingelheim GmbH (Germany)
        • Cellartis AB (Sweden)
        • ESTOOLS (United Kingdom)
        • GE Healthcare (United Kingdom)
        • Novartis AG (Switzerland)
        • Novo Nordisk A/B (Denmark)
        • Regenics A/S (Norway)
        • Sanofi-Aventis (France)
        • Scottish Stem Cell Network (United Kingdom)
        • Stemride International Ltd (United Kingdom)
        • TATAA Biocenter (Sweden)
        • UK National Stem Cell Network (United Kingdom)
        • UK Stem Cell Bank (UKNSCB) (United Kingdom)
      • 2.1.2.6 European Market Overview by Country
        • The United Kingdom
        • Germany
        • France
        • Spain
        • Sweden
        • Rest of Europe
    • 2.1.3 Asia-Pacific
      • 2.1.3.1 Market Overview by Asia-Pacific Region
      • 2.1.3.2 Market Overview by hESC Technology
      • 2.1.3.3 Market Overview by hESC Therapeutic Area
      • 2.1.3.4 hESC Technology Market Overview by Asia-Pacific Region
        • Stem Cell Transplants
        • Cell Based Genomics
        • Xenotransplants
        • Other Stem Cell Technologies
      • 2.1.3.5 Major Market Players
        • Australian Stem Cell Centre (Australia)
        • CellResearch Corporation Pte Ltd (Singapore)
        • National Center for Biological Sciences (India)
        • New South Wales Stem Cell Network (Australia)
        • Reliance Life Sciences (India)
        • RNL BIO (South Korea)
        • SinoCells BioTechnologies Co., Ltd. (China)
        • Stem Cell Sciences KK (Japan)
        • StemTech International Sdn Bhd (Malaysia)
        • Taiwan Society for Stem Cell Research (Taiwan)
      • 2.1.3.6 Asia-Pacific Market Overview by Country
        • India
        • Role of Governing Bodies
        • Latest Trends in Stem Cells Therapy
        • Future of Stem Cells in India Primed for Growth
        • Indian Stem Cells™ Company Scenario
        • Outlook
        • China
        • Japan
        • Australia
        • Rest of Asia-Pacific
    • 2.1.4 Rest of World
      • 2.1.4.1 Market Overview by Rest of World Region
      • 2.1.4.2 Market Overview by hESC Technology
      • 2.1.4.3 Market Overview by hESC Therapeutic Area
      • 2.1.4.4 Major Market Players
        • Cell Cure Neurosciences Ltd. (Israel)
        • Gamida Cell Ltd. (Israel)

3. GUIDE TO THE INDUSTRY

  • 3.1 North America
    • 3.1.1 Canada
    • 3.1.2 United States
  • 3.2 Europe
    • 3.2.1 Denmark
    • 3.2.2 France
    • 3.2.3 Germany
    • 3.2.4 Norway
    • 3.2.5 Spain
    • 3.2.6 Sweden
    • 3.2.7 Switzerland
    • 3.2.8 The Netherlands
    • 3.2.9 United Kingdom
  • 3.3 Asia-Pacific
    • 3.3.1 Australia
    • 3.3.2 China
    • 3.3.3 India
    • 3.3.4 Japan
    • 3.3.5 Korea
    • 3.3.6 Malaysia
    • 3.3.7 Singapore
    • 3.3.8 South Korea
    • 3.3.9 Taiwan
    • 3.3.10 Thailand
  • 3.4 Rest of World
    • 3.4.1 Israel
    • 3.4.2 South Africa

4. ANNEXURE

  • 4.1 Research methodology
  • 4.2 The Questionnaire
  • 4.3 Feedback

Charts & Graphs

GLOBAL MARKET PERSPECTIVE

  • Chart 1: Stem Cell Types - Properties
  • Chart 2: Stem Cell Research (2009): The Nations with Embryos Created for Research by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 3: Stem Cell Research (2009): The Nations with Existing Stem Cell Lines by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 4: Stem Cell Research (2009): The nations with No Explicit Stem Cell Research Policy by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 5: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in USD Million
  • Chart 6: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 7: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
  • Chart 8: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
  • Chart 9: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other
  • Chart 10: Global Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 11: Glance at 2007, 2010 and 2015 Global Stem Cell Transplants Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 12: Global Cell Based Genomics Market Analysis (2007-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 13: Glance at 2007, 2010 and 2015 Global Cell Based Genomics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 14: Global Xenotransplants Market Analysis (2007-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 15: Glance at 2007, 2010 and 2015 Global Xenotransplants Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 16: Global Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 17: Glance at 2007, 2010 and 2015 Global Other Stem Cell Technologies Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 18: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in CNS by Geographic Region North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 19: Glance at 2007, 2010 and 2015 Global CNS Market Share (%) of Human Embryonic Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 20: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Tissue Engineering by Geographic Region North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 21: Glance at 2007, 2010 and 2015 Global Tissue Engineering Market Share (%) of Human Embryonic Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 22: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Oncology by Geographic Region North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 23: Glance at 2007, 2010 and 2015 Global Oncology Market Share (%) of Human Embryonic Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 24: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Cardiology by Geographic Region North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 25: Glance at 2007, 2010 and 2015 Global Cardiology Market Share (%) of Human Embryonic Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 26: Global Human Embryonic Stem Cells Market Analysis (2007-2015) in Other Disease Areas by Geographic Region North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 27: Glance at 2007, 2010 and 2015 Global Other Disease Areas Market Share (%) of Human Embryonic Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET PERSPECTIVE

  • Chart 28: The Projection of Largest Regions in terms of Market Growth for Human Embryonic Stem Cells by Geography - Asia-Pacific, Europe and North America
  • Chart 29: Global Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 30: Glance at 2007, 2010 and 2015 Global Human Embryonic Stem Cells Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

NORTH AMERICA

  • Chart 31: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 32: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 33: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 34: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
  • Chart 35: North American Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
  • Chart 36: Glance at 2007, 2010 and 2015 North American Human Embryonic Stem Cells Market Share (%)by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other
  • Chart 37: North American Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 38: Glance at 2007, 2010 and 2015 North American Stem Cell Transplants Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 39: North American Cell Based Genomics Market Analysis (2007-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 40: Glance at 2007, 2010 and 2015 North American Cell Based Genomics Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 41: North American Xenotransplants Market Analysis (2007-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 42: Glance at 2007, 2010 and 2015 North American Xenotransplants Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 43: North American Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 44: Glance at 2007, 2010 and 2015 North American Other Stem Cell Technologies Market Share (%) by Geographic Region - United States, Canada and Mexico

The United States

  • Chart 45: United States Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 46: Glance at 2007, 2010 and 2015 United States Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Canada

  • Chart 47: Canadian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 48: Glance at 2007, 2010 and 2015 Canadian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Mexico

  • Chart 49: Mexican Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 50: Glance at 2007, 2010 and 2015 Mexican Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

EUROPE

  • Chart 51: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
  • Chart 52: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
  • Chart 53: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 54: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
  • Chart 55: European Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
  • Chart 56: Glance at 2007, 2010 and 2015 European Human Embryonic Stem Cells Market Share (%) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other
  • Chart 57: European Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
  • Chart 58: Glance at 2007, 2010 and 2015 European Stem Cell Transplants Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
  • Chart 59: European Cell Based Genomics Market Analysis (2007-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
  • Chart 60: Glance at 2007, 2010 and 2015 European Cell Based Genomics Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
  • Chart 61: European Xenotransplants Market Analysis (2007-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
  • Chart 62: Glance at 2007, 2010 and 2015 European Xenotransplants Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe
  • Chart 63: European Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe in USD Million
  • Chart 64: Glance at 2007, 2010 and 2015 European Other Stem Cell Technologies Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe

United Kingdom

  • Chart 65: United Kingdom Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 66: Glance at 2007, 2010 and 2015 United Kingdom Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Germany

  • Chart 67: German Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 68: Glance at 2007, 2010 and 2015 German Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

France

  • Chart 69: French Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 70: Glance at 2007, 2010 and 2015 French Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Spain

  • Chart 71: Spanish Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 72: Glance at 2007, 2010 and 2015 Spanish Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Sweden

  • Chart 73: Swedish Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 74: Glance at 2007, 2010 and 2015 Swedish Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Rest of Europe

  • Chart 75: Rest of Europe Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 76: Glance at 2007, 2010 and 2015 Rest of Europe Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

ASIA-PACIFIC

  • Chart 77: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
  • Chart 78: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific
  • Chart 79: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 80: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
  • Chart 81: Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
  • Chart 82: Glance at 2007, 2010 and 2015 Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other
  • Chart 83: Asia-Pacific Stem Cell Transplants Market Analysis (2007-2015) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
  • Chart 84: Glance at 2007, 2010 and 2015 Asia-Pacific Stem Cell Transplants Market Share (%) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific
  • Chart 85: Asia-Pacific Cell Based Genomics Market Analysis (2007-2015) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
  • Chart 86: Glance at 2007, 2010 and 2015 Asia-Pacific Cell Based Genomics Market Share (%) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific
  • Chart 87: Asia-Pacific Xenotransplants Market Analysis (2007-2015) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific in USD Million 170
  • Chart 88: Glance at 2007, 2010 and 2015 Asia-Pacific Xenotransplants Market Share (%) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific
  • Chart 89: Asia-Pacific Other Stem Cell Technologies Market Analysis (2007-2015) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific in USD Million
  • Chart 90: Glance at 2007, 2010 and 2015 Asia-Pacific Other Stem Cell Technologies Market Share (%) by Geographic Region - India, China, Japan, Australia and Rest of Asia-Pacific

India

  • Chart 91: Indian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 92: Glance at 2007, 2010 and 2015 Indian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

China

  • Chart 93: Chinese Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 94: Glance at 2007, 2010 and 2015 Chinese Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Japan

  • Chart 95: Japanese Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 96: Glance at 2007, 2010 and 2015 Japanese Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Australia

  • Chart 97: Australian Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 98: Glance at 2007, 2010 and 2015 Australian Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

Rest of Asia-Pacific

  • Chart 99: Rest of Asia-Pacific Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 100: Glance at 2007, 2010 and 2015 Rest of Asia-Pacific Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other

REST OF WORLD

  • Chart 101: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Geographic Region - Brazil, Israel, Columbia, Africa and Other in USD Million
  • Chart 102: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Geographic Region - Brazil, Israel, Columbia, Africa and Other
  • Chart 103: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other in USD Million
  • Chart 104: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other
  • Chart 105: Rest of World Human Embryonic Stem Cells Market Analysis (2007-2015) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other in USD Million
  • Chart 106: Glance at 2007, 2010 and 2015 Rest of World Human Embryonic Stem Cells Market Share (%) by Therapeutic Area - CNS, Tissue Engineering, Oncology, Cardiology and Other
Back to Top